BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6413685)

  • 1. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.
    van Riel PL; Gribnau FW; van de Putte LB
    J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 3. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A; Kunishima DH; Harralson AF; Simon TM
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin in the treatment of rheumatoid arthritis. A two-year study.
    Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J
    Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
    Giannini EH; Person DA; Brewer EJ; Parks DB
    J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auranofin in rheumatoid arthritis.
    Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
    J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
    [No Abstract]   [Full Text] [Related]  

  • 11. Gold excretion and retention during auranofin treatment: a preliminary report.
    Gottlieb NL
    J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
    J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold in rheumatoid arthritis; the past, present and future. Proceedings of a symposium held in Copenhagen, April 15-16, 1983.
    Scand J Rheumatol Suppl; 1983; 51():1-139. PubMed ID: 6426042
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of chrysothiotherapy in the treatment of progressive polyarthritis].
    Vojtísek O; Dostál C; Pavelka K
    Fysiatr Revmatol Vestn; 1984 Apr; 62(2):106-12. PubMed ID: 6430770
    [No Abstract]   [Full Text] [Related]  

  • 19. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H; Tausch G; Teherani DK
    Wien Klin Wochenschr Suppl; 1984; 156():16. PubMed ID: 6442049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.